I'm window shopping for shares again, and there are plenty of goodies for sale. Should I pop Serco Group (LSE: SRP) into my basket?
Prisons and hospital outsourcing company Serco Group is on a roll right now. Its share price is up 10% in the last month, after it reported a 27% rise in full-year profits for 2012 to £302m. The market understandably likes this stock right now. Should I buy it?
Recent performance is particularly impressive, because I would have expected Serco Group to struggle at the moment. It does a lot of outsourcing for the public sector, both in the UK and US, and with government budgets under pressure, its bottom line should be under pressure. It was certainly squeezed in the US, which makes up 20% of its sales, where federal government spending cuts knocked 14% off organic revenues. Serco more than offset these losses by winning a record £5.8bn of new global contracts, while its order book rose nearly 7% to £19.1bn. Group revenue rose 5.7% to around £4.9bn. The dividend was lifted 20% to 10.10p. Investors were understandably happy.
I'm happy to see that Serco generates more than 45% of total group revenue outside the UK, up from 40% in 2011. Its Australasian, Middle Eastern, Asian and African operations posted organic growth of 22% last year, as management seeks superior growth prospects and wider margins in emerging markets. This also helps offset political risk in the UK. While Serco has benefited from the coalition's welfare reforms, it constantly risks political backlash. In 2011 it was pilloried for driving prisoners to court in black cabs, while last month, the National Audit Office recently accused Serco of fiddling figures to hit performance targets at its out-of-hours GP service in Cornwall. Given the political dangers, and shrinking public sector budgets, I'm glad to see Serco looking further afield.
With a £31bn pipeline of new projects, management has good reason to be confident about the future. The board is even bullish about the US opportunities, although it did warn that investors should only expect "modest improvement" in organic growth this year. On a current yield of 1.7%, some investors may be hoping for more income (others will be glad to see Serco plough the money back into its business). But the recent 20% hike, covered a generous 4.2 times, suggests there is scope for further dividend growth as profits rise.
Watch and wait
Forecast earnings per share growth of 2% this year is disappointing, although it should rally to 10% in 2014. Revenues are expected to grow from £4.91bn in 2012 to £5.17bn this year and £5.47bn in 2014. Broker views are mixed. Credit Suisse is neutral, but JP Morgan Cazenove is overweight and Liberum Capital and Espirito Santo both hail Serco a buy, the latter with a £7.10 target price. This stock looks pretty fairly valued at 14.4 times earnings. Definitely one to add to your watchlist, if markets fall a little further.
Serco is good, but it isn't good enough to feature in our special report 5 Shares To Retire On. This free report by Motley Fool share analysts names five FTSE 100 favourites to secure your retirement. To find out more, download this report now. It won't cost you a penny, so click here.